American Century Companies Inc. boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,273,523 shares of the company's stock after buying an additional 125,107 shares during the period. American Century Companies Inc. owned about 0.75% of Option Care Health worth $29,546,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Graypoint LLC purchased a new position in shares of Option Care Health during the fourth quarter valued at $1,161,000. Charles Schwab Investment Management Inc. grew its stake in Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after acquiring an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. grew its stake in Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after acquiring an additional 18,992 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Option Care Health in the 4th quarter valued at about $327,000. Finally, Barclays PLC lifted its position in shares of Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Stock Performance
Shares of NASDAQ:OPCH traded up $0.22 during midday trading on Monday, hitting $34.95. The company's stock had a trading volume of 1,527,150 shares, compared to its average volume of 1,713,078. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $5.74 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 2.30 and a beta of 1.33. The stock's 50 day simple moving average is $32.47 and its 200 day simple moving average is $28.38.
Analyst Ratings Changes
Several research analysts have weighed in on OPCH shares. UBS Group started coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Barrington Research raised their target price on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $33.00.
View Our Latest Research Report on OPCH
Insider Buying and Selling at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
